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This editorial refers to ‘Evaluation of the diagnostic and
prognostic value of plasma D-dimer for abdominal aortic
aneurysm’†, by J. Golledge et al. on page 354
Over the last decade, abdominal aortic aneurysm (AAA), defined
as an aortic diameter ≥30 mm, has increasingly been recognized
as an important cause of mortality, accounting for 2.1% of deaths
in men aged .65 years. Large screening studies have suggested
a prevalence of 5.1–7.7% in men over the age of 64. Despite
advances in surgical and anaesthesiological techniques, mortality
remains high in patients with a ruptured AAA. Thus, elective
repair in appropriately selected individuals is advantageous, pre-
vents rupture, and thereby improves life expectancy. Simplified
abdominal ultrasound is recognized for its accuracy in identifying
AAA, with a reported sensitivity of 95% and specificity of 99%. Evi-
dence suggests that a single screening in the highest risk group is
sufficient to exclude risk from this disease for .10 years with
,2% of examinations insufficient to measure aortic diameters.1
Based on these data, ultrasound screening programmes have
been evaluated in an attempt to reduce AAA-related mortality in
the general population. The largest of these trials, the Multicentre
Aneurysm Screening Study, randomized a population-based sample
of 67 800 men aged 65–74 years in the UK. After 4 years of
follow-up, relative risk reduction of AAA-related deaths was 42%
[95% confidence interval (CI) 22–58%].2 A meta-analysis of
further randomized controlled trials subsequently confirmed
these results [odds ratio (OR) in AAA-related mortality, 0.56;
95% CI 0.44–0.72]. Moreover, long-term results showed a signifi-
cant reduction in emergency operations (OR 0.48; 95% CI 0.28–
0.83), while the number of elective operations increased signifi-
cantly (OR 2.81; 95% CI 2.40–3.30).3 Thus, a single ultrasound
examination reduces AAA-related mortality by facilitating elective
surgical intervention before rupture.4 In addition to evidence of a
mortality benefit and feasibility of implementation, relevant cost-
effectiveness studies of population-based AAA screening have
shown it to be in the same range as other cost-effective preventive
services such as screening for arterial hypertension or breast
cancer.
Ultrasound screening for AAA is
cost-effective, and single screening
excludes risk from this disease for
>10 years. Do we need more
diagnostic parameters than that?
National ultrasound screening programmes for AAA in men
between the ages of 65 and 75 who have ever smoked have
recently been implemented in England, Scotland, and in the USA
as part of Medicare.5 Ultrasound screening is a quick, inexpensive,
and non-invasive procedure that enables early detection of AAAs.
Once detected, an AAA can be monitored for size and surgical or
endovascular repair offered at a size threshold of ≥55 mm where
the risk of rupture is considered high.
As a matter of fact, most screening-detected AAAs are small
(,55 mm). In a screening study of 12 203 men ≥65 years of
age performed in Australia, 814 (6.7%) had a small AAA measuring
30–54 mm, but only 61 (0.5%) had a large AAA (≥55 mm). The
policy of early elective surgery for small AAAs (40–55 mm) has
not been demonstrated to save lives as it is associated with a
low rate of rupture of 1% per annum.6 However, risk of
rupture still exists in small AAAs (Table 1) with considerable inter-
patient variation, i.e. some small AAAs rapidly progress to rupture
and some large AAAs remain stable for prolonged periods.
The increase in identification of small AAAs resulting from
screening programmes, in association with an ageing population,
therefore creates a problem with surveillance offered to these
patients.6 Prognostic determinants for AAA progression in patients
with a small AAA ,55 mm are poorly defined, although 70% of
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small AAAs expand to a size requiring treatment within 10 years.
As ultrasound surveillance alone is incapable of detecting biological
activity it becomes apparent that not all patients with small AAAs
are protected, and rapid progression to rupture can occur unno-
ticed between scanning intervals.
Is there an incremental value of
D-dimer measurement?
Proteolysis and inflammation resulting in destruction of arterial
connective tissue are the pathological hallmarks of AAA. Thus, cir-
culating markers that reflect aortic wall destruction or inflamma-
tory activity could potentially help in the identification of
appropriate patients for different surveillance protocols and
intervention. Currently there is no clear consensus on which
markers are of most value to predict AAA growth reproducibly
or to select subsets of patients with small AAAs at high risk of
rupture.8 The study by Golledge et al.9 indeed raises hope
towards improved AAA patient management algorithms. In a mul-
tiple logistic regression model, plasma D-dimer levels are con-
firmed to have a powerful association with AAA diameter (OR
12.1 and 24.7 for cut-offs of 400 and 900 ng/mL as compared
with D-dimer levels up to 90 ng/mL, respectively). These findings
are consistent with previous small studies that assessed the associ-
ation of D-dimer and presence of an AAA.10 Importantly, the
present series is based on more subjects than all previous
studies combined, and results from patients with AAA are com-
pared with disparate patient groups: the diagnostic value of
D-dimer was assessed in both a population sample with 1260 sub-
jects identified from population AAA screening, and 132 subjects
with symptomatic peripheral artery disease or AAA from a referral
clinic. Elevated concentrations of fibrinogen degradation products
have been reported in association with atherosclerosis; however,
findings from the current study clearly show that plasma
D-dimer levels are distinctively higher in AAA patients as com-
pared with those with atherosclerosis, namely peripheral artery
disease alone. Finally, and probably most importantly, the
authors demonstrate an association between D-dimer and AAA
growth independent from baseline AAA diameter at a median of
5.5 years. Moreover, merging the information of initial D-dimer
level and AAA diameter, a separation of AAA growth as disparate
as 0.4 and 2.5 mm per year was achievable (Figure 1).
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Table 1 Correlation between maximum abdominal
aortic aneurysm diameter and risk of rupture7
Diameter
(cm)
1-year risk of
rupture (%)
5-year risk of
rupture (%)
3–3.9 0.4 1–2
4–4.9 1.1 5–13
5.5.9 3.3 25–38
6.6.9 9.4 No data
7–7.9 24 No data
Figure 1 Surveillance of abdominal aortic aneurysm.
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Could D-dimer be a target for
functional imaging in patients with
small AAA?
Aneurysms of the abdominal aorta are characterized by a dilated,
diseased wall frequently lined by a non-occlusive thrombus. Its
morphological characteristics are linked to AAA evolution in that
thrombus volume is highly correlated with the severity of aortic
dilatation and growth of such a thrombus, possibly predicting
aneurysm rupture. The pathogenic role is thought to be mediated
by inflammatory cell and proteolytic enzyme sequestration. An
active role for the mural thrombus in disease progression is sup-
ported by findings showing more degradation within an aneurysmal
wall lined by a thrombus compared with an adjacent wall in contact
with flowing blood. The thrombus mass itself is biologically active,
with fibrin generation demonstrable at the luminal interface, and
markers of fibrin turnover correlate with maximum aortic diam-
eter. The tightest association is noted for TAT complex and
D-dimer levels.11 This suggests that the predictive values of fibrino-
lytic components found in AAA patients mirror the proteolytic
activity of the mural thrombus, explaining the link between the
observed thrombus and the immediate risk of rupture.12 Thus,
the finding that elevated concentrations of D-dimer found in
AAA patients might be related to the biological activity of the
mural thrombus suggests that measurement of plasma D-dimer
could be a target for functional imaging of small AAA in addition
to ultrasound surveillance.
Can elevated D-dimer in patients
with a small AAA be differentiated
from other disease processes?
D-dimer is a fibrin degradation product present in negligible
amounts in healthy individuals, but thrombotic–fibrinolytic
disease conditions substantially increase D-dimer in plasma. Emer-
ging evidence endorses that D-dimer levels provide an indication
for a variety of diseases, including venous thromboembolism, disse-
minated intravascular coagulation, acute aortic dissection, stroke,
acute coronary syndrome, infectious diseases, and cancer.
As patients with conditions with potential activation of the
thrombotic–fibrinolytic system were not excluded from the
study by Golledge et al.,9 it is difficult to ascertain whether the
cause of high D-dimer is the expression of more mural thrombus
in patients with AAA or the result of various associated
co-morbidities. Most critically, the high prevalence of cardiovas-
cular disease is associated with the presence of AAA. Although
elevated concentrations of fibrinogen degradation products have
been reported in association with atherosclerosis, Golledge et al.
demonstrate that plasma D-dimer concentrations are distinctively
higher in AAA patients as compared with those with atherosclero-
sis, namely peripheral artery disease.
Conclusion
Ultrasound screening is not limited to identifying patients with
large AAAs (.55 mm) for repair, but includes the identification
of patients with small AAAs (30–54 mm) at risk. It is unlikely
that D-dimer assessment will replace ultrasound as first-line diag-
nostic modality to diagnose the presence of AAA. It is postulated,
however, that biomarkers such as D-dimer measured at baseline
or during follow-up might provide important prognostic infor-
mation about subsequent aortic behaviour, thereby allowing for
more patient-specific management. Data of the present study are
important and suggest that the level of D-dimer found in AAA
patients mirrors the proteolytic activity of the mural thrombus
and allows for a better prediction of disease progression than
ultrasound surveillance alone.
Screening for AAA and continued surveillance incur costs to
health providers and some anxiety for patients. Both can be mini-
mized by using the maximum interval between surveillance visits
that does not compromise patient safety. Further studies are
surely required to establish whether D-dimer testing, alone or com-
binedwith other prognostic indicators, can be used to better identify
patients with high risk of small AAA progression or rupture.
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